Gain Therapeutics (GANX)
NASDAQ:GANX
Gain Therapeutics (GANX) Ownership Overview
3.33%
Insiders
1.83% Mutual Funds
4.75% Other Institutional Investors
1.20% ETFs
88.89% Public Companies and
Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 7.78% of the company’s stock is owned by Institutional Investors, 3.33% is owned by Insiders, and 88.89% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 930,784 | Insider | 2.42% | 1,815,029 | |
| 371,150 | Institution | 0.96% | 723,743 | |
| 371,150 | Institution | 0.96% | 723,743 | |
| 304,458 | Insider | 0.79% | 593,693 | |
| 301,433 | Institution | 0.78% | 587,794 | |
| 158,155 | Institution | 0.41% | 355,849 | |
| 89,860 | Institution | 0.23% | 175,227 | |
| 30,004 | Institution | 0.08% | 58,508 | |
| 30,000 | Insider | 0.08% | 58,500 | |
| 14,400 | Insider | 0.04% | 28,080 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 371,150 | Institution | 0.96% | 723,743 | |
| 301,433 | Institution | 0.78% | 587,794 | |
| 30,004 | Institution | 0.08% | 58,508 | |
| 1,011 | Institution | <0.01% | 1,971 | |
| 733 | Institution | <0.01% | 1,429 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 371,150 | Institution | 0.96% | 968,702 | |
| 88,686 | Institution | 0.23% | 172,938 |
FAQ
Who Owns Gain Therapeutics (GANX)?
According to the latest TipRanks data, approximately 4.75% of the company's stock is held by institutional investors, 3.33% is held by insiders, and 88.89% is held by retail investors.
What percentage of Gain Therapeutics (GANX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.75% of Gain Therapeutics (GANX) stock is held by institutional investors.
What percentage of Gain Therapeutics (GANX) stock is held by retail investors?
According to the latest TipRanks data, approximately 88.89% of Gain Therapeutics (GANX) stock is held by retail investors.
Who owns the most shares of Gain Therapeutics (GANX)?
Khalid Islam owns the most shares of Gain Therapeutics (GANX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.